{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:53:18Z","timestamp":1768312398876,"version":"3.49.0"},"reference-count":19,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Educ Pract Ed"],"accepted":{"date-parts":[[2013,2,26]]},"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>Diagnosis and treatment of latent tuberculosis infection (LTBI) is important to reduce risk of progression to active tuberculosis (TB) disease. For the past century the tuberculin skin test (TST) has been used as a measure of exposure to Mycobacterium tuberculosis (MTB), but this test has limitations in test performance, sensitivity and specificity. Interferon \u03b3 release assays (IGRA), like TST, measure host immune response to MTB. IGRA are designed to be more specific for the diagnosis of LTBI than TST in patients with previous BCG or exposure to non-tuberculous mycobacteria, detecting interferon \u03b3 generated by T cells in response to antigens more specific to MTB. Although developed as an alternative to TST, recent data, particularly in children, suggest IGRA have their own limitations. Superiority to TST as a diagnostic test in children has not been demonstrated. Neither test discriminates between current or past MTB infection, or between latent infection and active disease. This article reviews the current literature on sensitivity and specificity of IGRA in the diagnosis of LTBI, and summarises current NICE recommendations for the use of IGRA in combination with TST. Although not developed for this purpose, in clinical practice IGRA have also been used as a diagnostic test for active TB. The gold standard for diagnosis of active TB disease is microbiological confirmation by culture of MTB. This article discusses the utility of IGRA as an adjunct to diagnosis of active TB disease, but emphasises that IGRA do not have sufficient sensitivity or specificity to exclude or confirm active TB disease.<\/jats:p>","DOI":"10.1136\/archdischild-2013-303641","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T21:22:27Z","timestamp":1365715347000},"page":"99-105","source":"Crossref","is-referenced-by-count":35,"title":["How to use: interferon \u03b3 release assays for tuberculosis"],"prefix":"10.1136","volume":"98","author":[{"given":"Louisa","family":"Pollock","sequence":"first","affiliation":[{"name":"Academic Department of Paediatrics, Department of Medicine, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robindra","family":"Basu Roy","sequence":"additional","affiliation":[{"name":"Academic Department of Paediatrics, Department of Medicine, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[{"name":"Academic Department of Paediatrics, Department of Medicine, Imperial College London, London, UK"},{"name":"Vaccinology Theme, MRC Unit, The Gambia, Fajara, Gambia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"2025090502152166000_98.3.99.1","unstructured":"World Health Organization. Global Tuberculosis Report 2012. World Health Organization, Geneva, 2012."},{"key":"2025090502152166000_98.3.99.2","unstructured":"Health Protection Agency. Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK, 2012. London: Health Protection Agency, 2012."},{"key":"2025090502152166000_98.3.99.3","first-page":"90","article-title":"Contacts of cases of active pulmonary tuberculosis","volume":"50","author":"Grzybowski","year":"1975","journal-title":"Bull Int Union Tuberc"},{"key":"2025090502152166000_98.3.99.4","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.3.247"},{"key":"2025090502152166000_98.3.99.5","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025090502152166000_98.3.99.6","doi-asserted-by":"crossref","unstructured":"Smieja MJ Marchetti CA Cook DJ . Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000;(2):CD001363.","DOI":"10.1002\/14651858.CD001363"},{"key":"2025090502152166000_98.3.99.7","unstructured":"National Institute for Health and Clinical Excellence. NICE Guideline CG117: Tuberculosis . Clinical management and diagnosis of tuberculosis, and measures for its prevention and control , 2011."},{"key":"2025090502152166000_98.3.99.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03555.x"},{"key":"2025090502152166000_98.3.99.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70167-0"},{"key":"2025090502152166000_98.3.99.10","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0631"},{"key":"2025090502152166000_98.3.99.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.02.019"},{"key":"2025090502152166000_98.3.99.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1613OC"},{"key":"2025090502152166000_98.3.99.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00115110"},{"key":"2025090502152166000_98.3.99.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0026OC"},{"key":"2025090502152166000_98.3.99.15","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318214b915"},{"key":"2025090502152166000_98.3.99.16","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0770"},{"key":"2025090502152166000_98.3.99.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00153408"},{"key":"2025090502152166000_98.3.99.18","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.169805"},{"key":"2025090502152166000_98.3.99.19","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247"}],"container-title":["Archives of disease in childhood - Education &amp; practice edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-303641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:16:00Z","timestamp":1757063760000},"score":1,"resource":{"primary":{"URL":"https:\/\/ep.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-303641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,5,13]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1136\/archdischild-2013-303641"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-303641","relation":{},"ISSN":["1743-0585","1743-0593"],"issn-type":[{"value":"1743-0585","type":"print"},{"value":"1743-0593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]}}}